These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28934253)

  • 1. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
    Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
    PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].
    HUANG XS; ZHAO SP; BAI L; ZHANG Q; HU M; ZHAO W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):809-13. PubMed ID: 21092650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.
    Li R; Chen LZ; Zhao W; Zhao SP; Huang XS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1173-8. PubMed ID: 27544029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha. Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice.
    Prieur X; Lesnik P; Moreau M; Rodríguez JC; Doucet C; Chapman MJ; Huby T
    Biochim Biophys Acta; 2009 Aug; 1791(8):764-71. PubMed ID: 19362162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
    Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
    Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-hyperlipidemic effects of Poria cocos (Schw.) Wolf extract: Modulating cholesterol homeostasis in hepatocytes via PPARα pathway.
    Zhang X; Lin W; Lei S; Zhang S; Cheng Y; Chen X; Lu Y; Zhao D; Zhang Y; Guo C
    J Ethnopharmacol; 2024 Mar; 321():117532. PubMed ID: 38048892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
    Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
    Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
    Moriarty PM; Roth EM; Karns A; Ye P; Zhao SP; Liao Y; Capuzzi DM; Bays HE; Zhang F; Liu S; Reichman AJ; Brusco OA; Lu G; Lerman S; Duan Z; Guo S; Liu PL; Zhao J; Zhang Y; Li S
    J Clin Lipidol; 2014; 8(6):568-575. PubMed ID: 25499939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats.
    Cao Y; Bei W; Hu Y; Cao L; Huang L; Wang L; Luo D; Chen Y; Yao X; He W; Liu X; Guo J
    Phytomedicine; 2012 Jun; 19(8-9):686-92. PubMed ID: 22554715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone regulates the hypotriglyceridemic gene APOA5.
    Prieur X; Huby T; Coste H; Schaap FG; Chapman MJ; Rodríguez JC
    J Biol Chem; 2005 Jul; 280(30):27533-43. PubMed ID: 15941710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Xuezhikang capsule on gene expression profile in brown adipose tissue of obese spontaneously hypertensive rats.
    Zhang S; Jiang Y; Wang X; Zhang H; Gu P; Gong Z; Jiang W; Zhang Y; Zhu Y
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115700. PubMed ID: 36126782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes.
    Duncan RE; Archer MC
    Lipids; 2008 Jul; 43(7):619-27. PubMed ID: 18509688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
    Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen lowers triglyceride via regulating hepatic APOA5 expression.
    Luo F; Guo Y; Ruan GY; Peng R; Li XP
    Lipids Health Dis; 2017 Apr; 16(1):72. PubMed ID: 28376804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
    Dorfmeister B; Brandlhofer S; Schaap FG; Hermann M; Fürnsinn C; Hagerty BP; Stangl H; Patsch W; Strobl W
    Diabetologia; 2006 Jun; 49(6):1324-32. PubMed ID: 16570166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metformin reduces plasma triglycerides in ob/ob obese mice via inhibiting the hepatic apoA5 expression].
    Huang X; Li R; Chen L; Dai W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1389-1394. PubMed ID: 29317579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the regulation of lipid metabolism and its mechanism of the iridoids rich fraction in Valeriana jatamansi Jones.
    Zhu J; Xu K; Zhang X; Cao J; Jia Z; Yang R; Ma C; Chen C; Zhang T; Yan Z
    Biomed Pharmacother; 2016 Dec; 84():1891-1898. PubMed ID: 27832992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.